The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Preclinical studies identifying carboplatin as a viable cisplatin alternative
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cisplatin : current status and new developments
Prestayko, A. W., Crooke, S. T., Carter, S. K., & Laboratories, B. (1980) · Cited by 747
High dose Cis-platinum diammine dichloride.Amelioration of renal toxicity by mannitol diuresis
Hayes, D. M., Cvitkovic, E., Golbey, R. B., Scheiner, E., Helson, L., & Krakoff, I. H. (1977) · Cancer · doi:10.1002/1097-0142(197704)39:4<1372::aid-cncr2820390404>3.0.co;2-j · Cited by 626
The Mechanism of Action of Antitumor Platinum Compounds
Roberts, J. J., & Thomson, A. J. (1979) · Progress in Nucleic Acid Research and Molecular Biology · doi:10.1016/s0079-6603(08)60799-0 · Cited by 411
Cisplatin (cis-diamminedichloroplatinum II)
Prestayko, A. W., D'Aoust, J. C., Issell, B. F., & Crooke, S. T. (1979) · Cancer Treatment Reviews · doi:10.1016/s0305-7372(79)80057-2 · Cited by 405
Molecular Actions and Targets for Cancer Chemotherapeutic Agents
Sartorelli, A. C., Lazo, J. S., & Bertino, J. R. (1981) · Medical Entomology and Zoology · Cited by 360
Toxic effects of cis-dichlorodiammineplatinum(II) in man.
Hoff, V., Schilsky, R. L., Reichert, C. M., Rl, R., Rozencweig, M., Rc, Y., & Muggia, F. M. (1980) · PubMed · Cited by 336
Long term effect of Cis-Diamminedichloride platinum (CDDP) on renal function and structure in man
Dentino, M. E., Luft, F. C., Yum, M. N., Williams, S. D., & Einhorn, L. H. (1978) · Cancer · Cited by 305
Qualitative and quantitative aspects of intercalator-induced DNA strand breaks
Ross, W. E., Glaubiger, D., & Kohn, K. W. (1979) · Biochimica et Biophysica Acta (BBA) - Nucleic Acids and Protein Synthesis · doi:10.1016/0005-2787(79)90124-2 · Cited by 237
Wiltshaw, E., & Kröner, P. T. (1976) · PubMed · Cited by 178
Anti-tumour platinum complexes : relationships between chemical properties and activity
Cleare, M. J., Hydes, P. C., Malerbi, B. W., & Watkins, D. M. (1978) · Biochimie · doi:10.1016/s0300-9084(78)80568-9 · Cited by 174
Cited by
The resurgence of platinum-based cancer chemotherapy
Kelland, L. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2167 · Cited by 4,717
Cellular processing of platinum anticancer drugs
Wang, D., & Lippard, S. J. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1691 · Cited by 3,801
Molecular mechanisms of cisplatin resistance
Galluzzi, L., Senovilla, L., Vitale, I., Michels, J., Martins, I., Kepp, O., Castedo, M., & Kroemer, G. (2012) · Oncogene · doi:10.1038/onc.2011.384 · Cited by 2,760
Carboplatin dosage: prospective evaluation of a simple formula based on renal function.
Calvert, A. H., Newell, D. R., Gumbrell, L. A., O'Reilly, S., Burnell, M., Boxall, F. E., Siddik, Z. H., Judson, I. R., Gore, M. E., & Wiltshaw, E. (1989) · Journal of Clinical Oncology · doi:10.1200/jco.1989.7.11.1748 · Cited by 1,866
Systems biology of cisplatin resistance: past, present and future
Galluzzi, L., Vitale, I., Michels, J., Brenner, C., Szabadkai, G., Harel-Bellan, A., Castedo, M., & Kroemer, G. (2014) · Cell Death & Disease · doi:10.1038/cddis.2013.428 · Cited by 782
Metadata
- Authors
- Harrap, K. R.
- Venue
- Cancer Treatment Reviews
- Publisher
- Elsevier BV
- Published
- 1985-09
- Volume
- 12
- Pages
- 21-33
- ISSN
- 0305-7372 (ISSN-L)
- OpenAlex
- W2044640058
- Cited by
- 259
- References
- 15
- FWCI
- 1.69
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Preclinical studies identifying carboplatin as a viable cisplatin alternative. https://app.cochat.ai/papers/10.1016/0305-7372(85)90015-5
- The paper
- Harrap, K. R. (1985). Preclinical studies identifying carboplatin as a viable cisplatin alternative. Cancer Treatment Reviews. https://doi.org/10.1016/0305-7372(85)90015-5
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.